Anti-Tuberculosis Drugs and Adverse Events

Hannah Yejin Kim, Jin Gun Cho, Onno W. Akkerman, Xavier Padanilam, Barbara Seaworth, Jan Willem C. Alffenaar*

*Corresponding author voor dit werk

OnderzoeksoutputAcademicpeer review

56 Downloads (Pure)

Samenvatting

Anti-tuberculosis (TB) drugs can cause adverse drug reactions, particularly the older second-line drugs. Early intervention and adequate management of adverse drug reactions are important to prevent complications. Laboratory testing at baseline and during treatment, in addition to clinical monitoring, is protocolized to improve patient and treatment management. This chapter provides an overview of the most frequent and severe adverse effects caused by the first-and second-line drugs used for the treatment of tuberculosis. An approach on how to manage the adverse drugs effects is briefly described.

Originele taal-2English
TitelEssential Tuberculosis
UitgeverijSpringer International Publishing AG
Hoofdstuk13
Pagina's121-129
Aantal pagina's9
ISBN van elektronische versie9783030667030
ISBN van geprinte versie9783030667054
DOI's
StatusPublished - 1-jan.-2021

Vingerafdruk

Duik in de onderzoeksthema's van 'Anti-Tuberculosis Drugs and Adverse Events'. Samen vormen ze een unieke vingerafdruk.

Citeer dit